Compare TTK HEALTHCARE with VENUS REMEDIES - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs VENUS REMEDIES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE VENUS REMEDIES TTK HEALTHCARE/
VENUS REMEDIES
 
P/E (TTM) x 10.9 -15.1 - View Chart
P/BV x 1.6 1.0 155.9% View Chart
Dividend Yield % 1.0 0.0 -  

Financials

 TTK HEALTHCARE   VENUS REMEDIES
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-19
VENUS REMEDIES
Mar-18
TTK HEALTHCARE/
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs1,215126 965.1%   
Low Rs61061 998.5%   
Sales per share (Unadj.) Rs444.4301.8 147.2%  
Earnings per share (Unadj.) Rs17.2-24.9 -69.3%  
Cash flow per share (Unadj.) Rs27.62.5 1,085.8%  
Dividends per share (Unadj.) Rs5.000-  
Dividend yield (eoy) %0.50-  
Book value per share (Unadj.) Rs177.9293.3 60.7%  
Shares outstanding (eoy) m14.1312.34 114.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.10.3 662.9%   
Avg P/E ratio x52.9-3.8 -1,407.4%  
P/CF ratio (eoy) x33.036.7 89.9%  
Price / Book Value ratio x5.10.3 1,608.6%  
Dividend payout %29.00-   
Avg Mkt Cap Rs m12,8941,154 1,117.6%   
No. of employees `0002.30.9 249.9%   
Total wages/salary Rs m1,307393 332.5%   
Avg. sales/employee Rs Th2,715.74,026.1 67.5%   
Avg. wages/employee Rs Th565.3425.0 133.0%   
Avg. net profit/employee Rs Th105.4-331.8 -31.8%   
INCOME DATA
Net Sales Rs m6,2793,724 168.6%  
Other income Rs m7823 344.4%   
Total revenues Rs m6,3563,747 169.7%   
Gross profit Rs m496395 125.5%  
Depreciation Rs m147338 43.4%   
Interest Rs m34354 9.5%   
Profit before tax Rs m393-275 -142.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m14932 471.2%   
Profit after tax Rs m244-307 -79.4%  
Gross profit margin %7.910.6 74.5%  
Effective tax rate %37.9-11.5 -330.4%   
Net profit margin %3.9-8.2 -47.1%  
BALANCE SHEET DATA
Current assets Rs m2,7172,638 103.0%   
Current liabilities Rs m1,5712,305 68.2%   
Net working cap to sales %18.38.9 204.2%  
Current ratio x1.71.1 151.1%  
Inventory Days Days32135 23.7%  
Debtors Days Days4746 100.7%  
Net fixed assets Rs m9914,871 20.3%   
Share capital Rs m141123 114.5%   
"Free" reserves Rs m2,3733,496 67.9%   
Net worth Rs m2,5143,619 69.5%   
Long term debt Rs m31,374 0.2%   
Total assets Rs m4,1587,509 55.4%  
Interest coverage x12.60.2 5,657.8%   
Debt to equity ratio x00.4 0.4%  
Sales to assets ratio x1.50.5 304.4%   
Return on assets %6.70.6 1,057.2%  
Return on equity %9.7-8.5 -114.3%  
Return on capital %16.91.6 1,070.5%  
Exports to sales %3.60-   
Imports to sales %0.513.9 3.6%   
Exports (fob) Rs m225NA-   
Imports (cif) Rs m31517 6.0%   
Fx inflow Rs m2250-   
Fx outflow Rs m71517 13.8%   
Net fx Rs m154-517 -29.8%   
CASH FLOW
From Operations Rs m173514 33.7%  
From Investments Rs m97-123 -78.4%  
From Financial Activity Rs m-307-387 79.4%  
Net Cashflow Rs m-384 -897.6%  

Share Holding

Indian Promoters % 65.4 32.9 199.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 0.2 2,055.6%  
FIIs % 5.2 0.6 896.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 66.4 38.9%  
Shareholders   12,723 20,121 63.2%  
Pledged promoter(s) holding % 0.0 36.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   ALKEM LABORATORIES  FRESENIUS KABI ONCO.  GLENMARK PHARMA  TORRENT PHARMA  STRIDES PHARMA SCIENCE  

Compare TTK HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 244 Points Lower, Nifty Ends Below 14,300; UltraTech Cement & HCL Tech Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (3QFY21); Net Profit Up 71.7% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, TTK HEALTHCARE has posted a net profit of Rs 77 m (up 71.7% YoY). Sales on the other hand came in at Rs 2 bn (up 8.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY20); Net Profit Down 8.3% (Quarterly Result Update)

Jan 30, 2020 | Updated on Jan 30, 2020

For the quarter ended December 2019, TTK HEALTHCARE has posted a net profit of Rs 45 m (down 8.3% YoY). Sales on the other hand came in at Rs 2 bn (up 11.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 38.0% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, TTK HEALTHCARE has posted a net profit of Rs 50 m (down 38.0% YoY). Sales on the other hand came in at Rs 1 bn (down 3.8% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

A Stock with 700% Return Potential Comes with Additional Payoffs(Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

11x Bankruptcy to Bluechip Stock: A Rare India Revival Story(Profit Hunter)

Apr 16, 2021

There is no stopping this 11-bagger stock from significant upside.

Top 3 Nifty ETFs to Buy Now(Fast Profits Daily)

Apr 20, 2021

In this video I tell you the three Nifty ETFs I think are the best.

Why Did the Market Crash on Monday?(Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Apr 20, 2021 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 5-YR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS